Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: Implications for predictive testing.
posted on 2008-04-28, 08:43authored byGabriela M. Almeida, Tiago L. Duarte, William P. Steward, George D.D. Jones
Multiple end-point analysis reveals cisplatin damage tolerance to be a chemoresistance mechanism in a NSCLC model: Implications for predictive testing.
History
Citation
International Journal of Cancer, 2008, 122 (8), pp.1810-9
Published in
International Journal of Cancer
Publisher
J Wiley & Sons
Available date
2008-04-28
Notes
This is the authors final draft of the version published as International Journal of Canacer, 2008, 122 (8), pp.1810-9. The published online version can be accessed at
http://www3.interscience.wiley.com/journal/117860573/abstract.